re-tender for the procurement of drugs for the year 2024-25 , activated charcoal ip 10 gm , acyclovir eye ointment ip 3% w/w , acyclovir oral suspension ip 400mg/5ml , allopurinol tab ip 100 mg , atropine eye drops bp/usp 1% , atropine eye ointment ip 1% w/w , bisacodyl suppository ip 5 mg , caffeine citrate oral solution ip20mg/ml (equivalent to 10mg of caffeine base) , calcium carbonate +vitamin d3 suspension 250 mg+ 125 iu , carbamazepine oral suspension bp/usp 100 mg/5 ml , carbidopa + levodopa tab ip 25 mg+ 100 mg , cilostazol tab ip 50 mg , clomiphene citrate tab ip 50 mg , clomipramine cap ip 25 mg , clomipramine tab 75 mg , dexamethasone tab ip 0.5 mg , dexmedetomidine inj usp 200 mcg/2 ml , dextran 40 in sodium chloride inj ip low molecular wt dextran 10% in sodium chloride inj 0.9% , diazepam inj ip 5 mg/ml , diazepam suppository 5 mg , digoxin inj ip 0.5 mg/2 ml , diltiazem inj ip 5 mg/ml , haloperidol tab ip 1.5mg , homatropine eye drops ip2% w/v , hydroxyzine tab ip 25 mg , ketorolac tromethamine inj ip 30 mg/ml , lignocaine hcl inj ip 4% w/v , lignocaine hcl inj ip(for iv use-preservative free) 2% w/v , lithium carbonate tab ip 300 mg , lorazepam inj ip 2 mg/ml , metoclopramide tab ip 10 mg , mifepristone tab ip 200 mg , nifedipine prolonged-release tab ip 20 mg , paracetamol suppository bp 80 mg , paracetamol suppository bp 170 mg , penicillin g potassium tab usp 4,00,000 units , pilocarpine nitrate eye drops ip2% w/v , pralidoxime chloride inj ip 1 gm , prednisolone acetate opthalmic suspension 1% , primaquine tab ip 7.5 mg , prochlorperazine inj ip 12.5 mg/ml , promethazine tab ip 10 mg , sodium valproate inj ip 100 mg/ml , sulfasalazine tab bp/usp 500 mg , thiopentone sodium inj ip 0.5 gram , verapamil tab ip 40 mg , warfarin sodium tab ip 1 mg , warfarin sodium tab ip 5 mg , methylergometrin maleate inj ip 200 mcg/ml , prostaglandin e2 gel 0.5 mg